Levodopa/carbidopa/entacapone-induced acute Pisa syndrome in a Parkinson's disease patient

被引:25
|
作者
Solla, Paolo [1 ]
Cannas, Antonino [1 ]
Congia, Socrate [1 ]
Floris, Gianluca [1 ]
Aste, Rosa [1 ]
Tacconi, Paolo [1 ]
Marrosu, Maria Giovanna [1 ]
机构
[1] Univ Cagliari, Inst Neurol, Ctr Disordini Movimento, Dipartimento Sci Cardiovasc & Neurol,Sez Neurol, I-09124 Cagliari, Italy
关键词
Pisa syndrome; Parkinson's disease; Dystonia; Entacapone/levodopa/carbidopa combination;
D O I
10.1016/j.jns.2008.07.017
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pisa syndrome (PS) is a dystonic lateroflexion of the trunk with a postural disturbance resembling the leaning tower of Pisa. Initially reported as a side effect related to antipsychotic therapy, this original dystonic Posture is also manifested in neurodegenerative disorders such as Alzheimer's disease and multiple system atrophy, or in rare idiopathic cases. Recent observations have described the onset of PS with subchronic course in patients affected by Parkinson's disease (PD). Here, we report on the acute development of PS in a parkinsonian patient during treatment with entacapone/levodopa/carbidopa combination. This case illustrates how, in contrast to previously well-known chronic/subchronic forms, this axial dystonic posture may occur in PD as an acute onset reversible type, related to levodopa treatment. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:154 / 156
页数:3
相关论文
共 50 条
  • [41] Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off
    Kuoppamaki, Mikko
    Leinonen, Mika
    Poewe, Werner
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (12) : 1709 - 1714
  • [42] Improved symptom control with fixed dose levodopa/carbidopa/entacapone versus conventional levodopa/carbidopa as first-line levodopa therapy in early Parkinson's disease patients
    Hauser, R. A.
    Panisset, M.
    Abbruzzese, G.
    Mancione, L.
    Dronamraju, N.
    Kakarieka, A.
    MOVEMENT DISORDERS, 2008, 23 (01) : S208 - S208
  • [43] Improved symptom control with fixed dose levodopa/carbidopa/entacapone versus levodopa/carbidopa as first-line levodopa therapy in early Parkinson's disease (PD) patients
    Hauser, Robert A.
    Panisset, Michel
    Abbruzzese, Giovanni
    Mancione, Linda
    Dronamraju, Nalina
    Kakarieka, Algirdas
    NEUROLOGY, 2008, 71 (02) : 154 - 154
  • [44] Nocturnal motor symptoms of Parkinson's disease and their treatment with the three-component drug levodopa/carbidopa/entacapone
    Kulua, T. K.
    Fedorova, N. V.
    Popovkina, O. A.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (09) : 45 - 50
  • [45] Two years' experience with levodopa-entacapone-carbidopa intestinal gel treatment in advanced Parkinson's disease
    Szatmari, Szabolcs
    Szasz, Jozsef Attila
    Constantin, Viorelia
    Mihaly, Istvan
    Torok, Arpad
    Ciorba, Marius
    Torok, Imola
    Kelemen, Krisztina
    Szasz, Peter
    Szilvester, Monika
    Baroti, Beata
    Frigy, Attila
    Orban-Kis, Karoly
    ORVOSI HETILAP, 2025, 166 (03) : 90 - 97
  • [46] PROFILE OF PATIENTS WITH ADVANCED PARKINSON'S DISEASE TREATED WITH LEVODOPA-ENTACAPONE-CARBIDOPA INTESTINAL GEL (LECIG)
    Szasz, J.
    Constantin, V.
    Kis, K. Orban
    Bataga, S.
    Neagoe, R.
    Ciorba, M.
    Krisztina, K.
    Mihaly, I.
    Szatmari, S.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [47] Real-world considerations regarding the use of the combination of levodopa, carbidopa, and entacapone (Stalevo®) in Parkinson's disease
    Reichmann, Heinz
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 15 - 20
  • [48] Levodopa-entacapone-carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease
    Othman, Mezin
    Bergquist, Filip
    Odin, Per
    Scharfenort, Monica
    Johansson, Anders
    Markaki, Ioanna
    Svenningsson, Per
    Dizdar, Nil
    Nyholm, Dag
    EUROPEAN JOURNAL OF NEUROLOGY, 2025, 32 (01)
  • [49] Levodopa-Entacapone-Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease - Interim Analysis of the ELEGANCE Study
    Weiss, Daniel
    Jost, Wolfgang H.
    Szasz, Jozsef Attila
    Pirtosek, Zvezdan
    Milanov, Ivan
    Tomantschger, Volker
    Kovacs, Norbert
    Staines, Harry
    Amlani, Bharat
    Smith, Niall
    van Laar, Teus
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2025,
  • [50] Mydriasis in a Parkinson's disease patient on low-dose carbidopa/levodopa
    Burdick, D. J.
    Griffith, A.
    Cole, A.
    Sia, C. M.
    Agarwal, P.
    MOVEMENT DISORDERS, 2013, 28 : S218 - S218